Lv1
32 积分 2024-11-03 加入
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model
1个月前
已完结
Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
1个月前
已完结
Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study
1个月前
已完结
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways
1个月前
已完结
Adalimumab for the treatment of pediatric Crohn’s disease
2个月前
已完结
Biosimilars for Pediatric Patients With Inflammatory Bowel Disease
2个月前
已完结
Mo1871 - Direct Costs of Care Among Patients with Inflammatory Bowel Disease before and after Initiation of Anti-TNF Therapy
2个月前
已完结
Epidemiology of Pediatric Inflammatory Bowel Disease
2个月前
已完结
Applying Cognitive Neuroscience to Juvenile Justice: The Role of Brain Development in Decision-Making
8个月前
已关闭
Cognitive Behavioral Therapy with Children and Adolescents
8个月前
已完结
皖公网安备34019202002308
